Experts Assess the Impact of Risk Assessment on Public Acceptance of Gene-edited CropsJuly 17, 2019
Modern biotechnology (transgenesis and gene editing) helps achieve an increase in food production without the need for more land area for agriculture. It is expected to continue contributing to achieving global food production and thus it is necessary for this technology to be widely accepted. For this reason, experts from DowDuPont published a review on how government regulations of gene-edited crops and public acceptance of these crops are affect each other.
The paper showed a comparison between the regulatory oversight of traditional crops and genetically modified crops. Government authorities rarely assessed traditional crops due to their remarkable track safety records. As for genetically modified crops, some have suggested that the rigorous regulatory oversight will instill consumer acceptance. However, this contradicts with the history of GM crops' acceptance which exhibited that arduous regulation has likely led to public distrust. This contributed to the notion that GM crops are risky. But in reality, the risks are similar to those of traditional crops'. Thus, the authors investigate if risk-disproportionate regulation leads to the validation of the public's fears and distrust towards controversial yet safe technologies.
The paper also states that risks are always involved when trying to gain the public's trust towards an underlying technology. These risks include confusing the purpose of risk assessment. For instance, when a voluminous data on risk assessment is presented to meet regulatory requirements, the real safety risks are not readily distinguishable from negligible risks. Another risk mentioned was the obstruction of the delivery of beneficial technologies to the market due to the time and cost it takes the developers to gather non-risk based regulatory approvals.
It was concluded that separating the goal of regulating technologies to protect public safety from the goal of attaining public acceptance may help avoid the risk of meeting neither goals. The authors also emphasized that education and outreach are a better use of government resources to gain public acceptance of beneficial technologies. However, it was noted that these efforts will be maximized if aimed at an audience who are willing to consider new information instead of an audience who already believes that they know everything about the technology. Factual communications from trusted and reliable sources were also highlighted to oppose misinformation commonly spread through social media.
See the complete review in Trends in Biotechnology.
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Hybrid Corn: High Yields and Nitrogen Efficient
- Experts Assess the Impact of Risk Assessment on Public Acceptance of Gene-edited Crops
- Four Companies Receive Permit to Import GM Products in Zambia
- Government Spokespersons Impressed by Progress in Agri-biotech Research in Uganda
- GM Tobacco Plants to Produce Industrial Proteins
- Scientists Decode DNA Secrets of World's Toughest Bean
- Gene Identified that Will Help Develop Plants to Fight Climate Change
- USDA Probes Detection of GE Wheat in US Agri Fields
- GM Crops Aid Transition of Pakistan from Subsistence to Commercial Farming
- Zero-Waste Plants Being Developed
- Maize Promoter Induces Cellulase Enzyme Expression in Maize Kernels
Beyond Crop Biotech
- Dairy-free Ice Cream Made from GE Yeast Sold Out
From the BICs
- Farmers from Madhya Pradesh Benefit from Project SAFFAL
- OsPEX5 Regulates Rice Spikelet Development, Study Shows
- Consumers in Costa Rica Show Favorable Attitudes on CRISPR Foods, Survey
Read the latest:
- Biotech Updates (November 29, 2023)
- Gene Editing Supplement (November 29, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: